Latest Vivanza Biosciences stock price
Vivanza Biosciences P/E Ratio
VIVANZA • P/E ratio not applicable due to negative earnings
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-0.17
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | 0.14 | 1 | Profit |
| Mar 2025 | -0.25 | -1 | Loss |
| Jun 2025 | 0.02 | 0 | Profit |
| Mar 2024 | -0.10 | 0 | Loss |
| Jun 2024 | 0.07 | 0 | Profit |
| Dec 2024 | 0.01 | 0 | Profit |
| Sept 2023 | 0.07 | 0 | Profit |
| Mar 2023 | -0.26 | 0 | Loss |
Profitable Companies in Healthcare Sector
Other profitable companies in Healthcare sector with valid P/E ratios
Sector Average PE
48.09
Sector Median PE
27.37
Lowest PE
1.1
Profitable Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |